Joseph D. Diaz

Statistics

Publications

Citations

1.1K

H-Index

Active since

1988

Affiliations

The University of Texas at San Antonio Health Science Center(Current)

AstraZeneca (United States)

University of South Florida

The University of Texas at San Antonio

Joseph D. Diaz is an author at The University of Texas at San Antonio Health Science Center specializing in pharmacotherapy, pharmacology, and clinical pharmacology.

Publications per year

1988–2020

Publications

Long-term safety and efficacy of benralizumab in patients with severe, uncontrolled asthma: 1-year results from the BORA phase 3 extension trial

William W. Busse, Eugene R. Bleecker, J Mark FitzGerald et al. · The Lancet Respiratory Medicine · 2018 · 311 citations

Pharmacy, Pharmacology, Pharmacotherapy +6

Rheumatic manifestations of human immunodeficiency virus infection

Alberto Berman, Luis R. Espinoza, Joseph D. Diaz et al. · The American Journal of Medicine · 1988 · 284 citations

Life Sciences, Immunology, Infectious Diseases +12

Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial

Tim Harrison, Pascal Chanez, Francesco Menzella et al. · The Lancet Respiratory Medicine · 2020 · 175 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +15

A randomized trial of the efficacy and safety of quilizumab in adults with inadequately controlled allergic asthma

Jeffrey M. Harris, Romeo Maciuca, Mary S. Bradley et al. · Respiratory Research · 2016 · 99 citations · Full text

Life Sciences, Immunology, Pharmacology +17

Persistence of Community-Acquired Respiratory Distress Syndrome Toxin-Producing Mycoplasma pneumoniae in Refractory Asthma

Jay I. Peters, Harjinder Singh, Edward G. Brooks et al. · CHEST Journal · 2011 · 58 citations · Full text

Medicine, Infectious Diseases, Internal Medicine +10

1–5 of 9